# Prognostic Value of Measuring CtDNA in a Cohort of Patients With Stage III and IV Upper Aero-digestive Tract (UADT) Cancer , Treated With Curative RADiOtherapy With or Without Concomitant Treatment.

> **NCT06479070** · NA · RECRUITING · sponsor: **Institut de Cancérologie de Lorraine** · enrollment: 188 (estimated)

## Conditions studied

- SCC - Squamous Cell Carcinoma
- Upper Aero-digestive Tract (UADT) Neoplasm

## Interventions

- **OTHER:** Blood samples

## Key facts

- **NCT ID:** NCT06479070
- **Lead sponsor:** Institut de Cancérologie de Lorraine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-30
- **Primary completion:** 2026-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 188 (ESTIMATED)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06479070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06479070, "Prognostic Value of Measuring CtDNA in a Cohort of Patients With Stage III and IV Upper Aero-digestive Tract (UADT) Cancer , Treated With Curative RADiOtherapy With or Without Concomitant Treatment.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06479070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*